Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,690,622
+$10,984,386 QoQ
Shares Held
1,755,152
+326.7% QoQ
Ownership
0.784%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#22
of 320 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $451,584,893 across 62 Biotechnology names. ADMA ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
544,994 | $42,656,680 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
193,215 | $21,452,661 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
724,508 | $17,576,564 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
201,979 | $17,562,074 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
134,019 | $16,428,049 | |
| 6 | MGTX |
MeiraGTx Holdings plc
|
1,105,421 | $14,934,237 | |
| 7 | ADMA |
Adma Biologics, Inc.
This page
|
1,755,152 | $14,690,622 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
421,374 | $14,280,364 |
All Filings in ADMA
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,690,622 | 1,755,152 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,706,236 | 411,347 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $12,359,424 | 677,600 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,977,576 | 544,173 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,776,325 | 427,036 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,124,321 | 409,492 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,624,531 | 269,652 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,732,311 | 386,809 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,820,066 | 431,133 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,622,042 | 245,764 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,414,471 | 534,175 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,831,948 | 791,047 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,092,523 | 1,109,085 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,345,393 | 708,578 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,727,947 | 2,249,471 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||